Effects of dorzolamide/timolol and tafluprost on intraocular pressure and pupil diameter in healthy dogs

ABSTRACT: This study aimed to evaluate and compare the effects of the fixed combination of dorzolamide/timolol with those of tafluprost on intraocular pressure (IOP) and pupil diameter (PD) in healthy dogs (n=10). Two experiments were conducted with an interval of 30 days. In both, IOP and PD were assessed at 8, 11, 14, 17, and 20h. Parameters were evaluated during baseline, treatment period of four days, and one day of post-treatment. During treatment phase, IOP decreased by 0.74 (P<0.05), 1.88 (P<0.01), 2.94 (P<0.001), and 3.10mmHg (P<0.01), in dorzolamide/timolol-treated eyes; and by 1.50, 2.18, 2.14, and 2.18mmHg (P<0.001), in tafluprost-treated eyes. PD decreased by 0.24 (P<0.01), 0.32 (P<0.01), 0.49 (P<0.001), and 0.40mm (P<0.001), in dorzolamide/timolol treated eyes; and by 2.31, 2.55, 2.43, and 2.70mm (P<0.001), in tafluprost-treated eyes. Dorzolamide/timolol and tafluprost were able to decrease IOP and PD in healthy dogs. However, a cumulative effect of the fixed combination of dorzolamide/timolol was more effective in reducing IOP, than tafluprost. Comparisons between treatments showed that tafluprost was more effective in reducing PD throughout the treatment phase.

Saved in:
Bibliographic Details
Main Authors: Dower,Nathalie Moro Bassil, Ribeiro,Alexandre Pinto, Maciel,Camila do Espirito Santo, Spiller,Paulo Roberto, Monteiro,Geovanna Barreira, Pizzinatto,Fábio Dumit, Yamauchi,Kelly Cristiane Ito
Format: Digital revista
Language:English
Published: Universidade Federal de Santa Maria 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782017000900603
Tags: Add Tag
No Tags, Be the first to tag this record!